Clinical trial Recruiting at 1 site Observational

Monitoring the safety and performance of Ennovate® Complex for scoliosis patients

Official title: Multicenter Post Market Clinical Follow-Up (PMCF) Study on the Safety and Performance of Ennovate® Complex - A Prospective Study on Scoliosis Patients

Run by Aesculap AG · NCT05281757 · Data updated 2026-11-12

This study looks at how safe and effective the Ennovate® Complex system is for treating scoliosis and other spinal issues in patients after their surgery.

More Idiopathic Scoliosis trials

Quick facts

Study typeObservational
SexAll
Enrollment200 (estimated)
SponsorAesculap AG
Industry-sponsored
Locations2 sites (Brno and 1 other locations)
StatusRecruiting
StartedFebruary 18, 2022
Main results expectedDecember 2026
Study endsOctober 2028
Registry record updatedJune 2, 2026
Trial IDNCT05281757 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates include patients aged 18 and older who have provided informed consent and are undergoing treatment for conditions like hyperkyphosis, hyperlordosis, or scoliosis.

Probably not a fit

Patients who are unable or unwilling to participate in follow-up examinations may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study collects data on the safety and performance of the Ennovate® Complex system used for treating various spinal deformities, including scoliosis. It involves multiple centers across different countries and focuses on documenting clinical and radiological outcomes for patients who have undergone posterior stabilization for the cervical spine. The study aims to provide valuable insights into the effectiveness of the implant system in real-world settings, ensuring ongoing safety monitoring post-market.

Why it matters

Potential benefit: If successful, this study could enhance the understanding of the Ennovate® Complex system's safety and efficacy, leading to improved treatment options for patients with spinal deformities.

How similar studies have gone: While this study is part of a post-market follow-up, similar observational studies have successfully monitored the safety and performance of medical devices in the past.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Informed consent in the documentation of clinical and radiological results of patients who are minimum 18 years old
* Informed consent in the documentation of clinical and radiological results of patients AND legal representative (parent) for patients who are younger than 18
* Patient's indication according to IFU
* Patient is not pregnant

Exclusion Criteria:

* Patient's clear unability or unwillingness to participate in follow-up examinations

Where it's running

  • Hospital Universiti Kebangsaan Malaysia (HUKM)
    Kuala Lumpur, Malaysia
    Recruiting
  • University Hospital Brno
    Brno, Czechia
    Suspended

Study contacts

  • Principal investigator: Mohd Hisam, Prof. Dr. — Hospital Universiti Kebangsaan Malaysia (HUKM)
  • Study coordinator: Sarah Mattes
  • Email: sarah.mattes@aesculap.de
  • Phone: +497461950

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.